Adenocarcinoma Of Esophagus Terminated Phase 2 Trials for Cisplatin (DB00515)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00216008Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.Treatment